WHO issues medical product alert on three contaminated oral liquid medicines in India

Health

World Health Organisation (WHO) has issued medical product alert on three contaminated oral liquid medicines identified in India and reported to WHO on October 8, 2025. The contaminated oral liquid medicines have been identified to be specific batches of COLDRIF, Respifresh TR and ReLife, manufactured by Sresan Pharmaceutical, Rednex Pharmaceuticals, and Shape Pharma.

 

The U.N. agency said that the Indian National Regulatory Authorities (NRAs) has been advised to consider targeted market surveillance, with particular attention to informal and unregulated supply chains where products may circulate undetected. NRAs are also advised to carefully evaluate the risks associated with any oral liquid medicines originating from the same manufacturing sites — particularly those produced since December 2024.

source:thehindu.com

Related News

Health
0 Views

Big Techas contempt for Indian public health - The Hindu

28 Oct,2025
Health
87 Views

Study finds eye scans could reveal biological ageing. heart disease risk

27 Oct,2025
Health
97 Views

Soren orders suspension of officials after four more thalassemia-affected children test HIV-positive; probe underway

27 Oct,2025
Health
50 Views

Life after a mastectomy: navigating challenges, heralding new beginnings

24 Oct,2025
Health
76 Views

Why pigeons are significant for public health managers

22 Oct,2025
Health
65 Views

WHO issues medical product alert on three contaminated oral liquid medicines in India

14 Oct,2025
Health
63 Views

Do we need more palliative medicine specialists in India?

13 Oct,2025
Health
69 Views

WHO seeks clarification from India if cough syrup has been exported to other countries

09 Oct,2025